Bartlett & Co’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Bartlett & Co’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$0	Sell	166 -1	-0.6%	-$3	﹤0.01%	1264
2023 Q3	$1K	Hold	167	–	–	﹤0.01%	1126
2023 Q2	$2K	Hold	167	–	–	﹤0.01%	1076
2023 Q1	$3K	Hold	167	–	–	﹤0.01%	961
2022 Q4	$3K	Hold	167	–	–	﹤0.01%	993
2022 Q3	$3K	Hold	167	–	–	﹤0.01%	1017
2022 Q2	$4K	Hold	167	–	–	﹤0.01%	1089
2022 Q1	$4K	Buy	+167	New	+$3.33K	﹤0.01%	948
2021 Q4	–	Sell	-167	Closed	-$5K	–	926
2021 Q3	$5K	Hold	167	–	–	﹤0.01%	777
2021 Q2	$5K	Buy	+167	New	+$4.54K	﹤0.01%	768

Other funds holding ZIVO

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Bartlett & Co's ZIVO Position: Q4 2023 in Review

Bartlett & Co reduced its Zivo Bioscience, Inc. Common Stock (ZIVO) stake by 0.6% in Q4 2023, selling an estimated $3 and leaving 166 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Bartlett & Co first reported a position in ZIVO in Q2 2021 and has held it in 10 quarters since. The position peaked at $5K in Q3 2021. 2 funds tracked by Wall St. Rank hold ZIVO as of Q4 2023.

Bartlett & Co held 166 shares of Zivo Bioscience, Inc. Common Stock worth $0 as of Q4 2023.
Bartlett & Co sold 1 Zivo Bioscience, Inc. Common Stock share in Q4 2023, an estimated $3.
Zivo Bioscience, Inc. Common Stock made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #1264 holding.
Bartlett & Co first reported a position in Zivo Bioscience, Inc. Common Stock in Q2 2021 and has held it in 10 quarters since.
Bartlett & Co's Zivo Bioscience, Inc. Common Stock position peaked at $5K in Q3 2021.
2 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.